A growing body of research shows that sleep quality, dietary sodium, and hypertension are more closely linked than once believed — and two major healthcare organizations are joining forces to address this triad of risks. As released in their Newsroom, the American Heart Association (AHA) has announced a new collaboration with the Sleep Matters Initiative at Brigham and Women’s Hospital, part of the Mass General Brigham system, to improve education and clinical practices surrounding these interconnected health factors.
A Comprehensive Educational Effort
As part of the AHA’s Hypertension, Sodium and Sleep Professional Education Initiative — supported financially by Jazz Pharmaceuticals — the partners will develop materials for both clinicians and patients. These resources aim to help healthcare providers better recognize how sleep patterns and sodium consumption influence blood pressure, and how addressing all three components together can improve cardiovascular outcomes.
“This effort allows us to look beyond separate risk factors and consider how behaviors and environmental factors tie them together,” said Mitch Elkind, M.D., M.S., FAHA, the Association’s chief science officer for brain health and stroke.
A Cyclical Relationship With Serious Health Consequences
High sodium intake is known to elevate blood pressure, but emerging evidence suggests it may also contribute to disrupted sleep. In turn, insufficient or poor‑quality sleep has been linked to hypertension and unhealthy eating habits, creating a cycle that can be difficult to break.
Charles Czeisler, Ph.D., M.D., F.R.C.P., who leads the Division of Sleep and Circadian Medicine at Brigham and Women’s Hospital, noted that both organizations have long shared an interest in understanding how sleep influences overall health. “This collaboration will help advance professional education and ultimately improve patient care,” he said.
Reflecting a Holistic View of Heart and Brain Health
The AHA recently added sleep to its Life’s Essential 8™ framework — a set of lifestyle factors considered foundational to long‑term cardiovascular health. The new initiative reinforces the organization’s broader efforts to highlight the relationship between sleep, brain health, and heart health, underscoring how integrated care can support better outcomes.
Jazz Pharmaceuticals, which focuses on conditions such as narcolepsy and idiopathic hypersomnia, expressed support for the initiative’s educational mission. “We’re proud to contribute to raising awareness on health issues affecting people with serious sleep disorders,” said Sarah McMahon, Ph.D., senior vice president and sleep franchise head at Jazz.
Expanding Access to Lifelong Learning
All materials created through the collaboration will be available through the American Heart Association’s Lifelong Learning professional education catalog, giving healthcare providers ongoing access to updated guidance at the intersection of sleep, sodium, and hypertension.
